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ABSTRACT 
Software development companies moving into the medical device 
domain often find themselves overwhelmed by the number of 
regulatory requirements they need to satisfy before they can 
market their device. Several international standards and guidance 
documents have been developed to help companies on their road 
to regulatory compliance but working their way through the 
various standards is a challenge in itself. In order to help software 
companies in the medical device domain, we have developed an 
integrated framework of medical device software development 
best practices called MDevSPICE®. This framework integrates 
generic software development best practices with medical device 
standards’ requirements enabling consistent and thorough 
assessment of medical device processes. 
MDevSPICE® can be used by software companies evaluating their 
readiness for regulatory audits as well as by large medical device 
manufacturers for selecting suitable software suppliers.   
The MDevSPICE® framework consists of a process reference 
model, a process assessment model, an assessment method, and 
training and certification schemes. The framework has been 
validated using expert reviews and through MDevSPICE® 
assessments in industry. In this paper, we describe the 
MDevSPICE® process assessment framework focusing on its 
benefits and significance for the medical device manufacturing 
community as learned from MDevSPICE® assessments conducted 
to date. 
Categories and Subject Descriptors 
D.2.0 [Software Engineering]: General - Standards.  
General Terms 
Management, Measurement, Documentation, Performance, 
Reliability, Standardization.  
Keywords 
MDevSPICE®, process assessment framework, medical device 
regulation, medical device software. 
1. INTRODUCTION 
Safety-critical software systems are increasingly affecting our 
lives and welfare as more and more software is embedded into 
medical devices, cars and airplanes each day. New approaches and 
international standards are being developed to ensure the safety of 
these systems before they are delivered. In order to market a 
medical device, for example, the manufacturer has to satisfy a 
number of regional regulatory requirements commonly achieved 
by following international standards and guidance issued by 
international standardizing bodies and regional regulatory 
authorities. To help software companies in the medical device 
domain in their attempt to reach regulatory compliance, we have 
developed an integrated framework of medical device software 
development best practices called MDevSPICE®. This framework 
integrates generic software development best practices with 
medical device standards’ requirements enabling robust software 
process assessments. The “SPICE” in MDevSPICE® reflects its 
foundation in the ISO/IEC 15504 (SPICE) series of standards for 
process assessment. Through validating the MDevSPICE® 
framework we provide evidence that process assessment can also 
help increase a company’s readiness for regulatory audits. 
Furthermore, the MDevSPICE® framework can also help larger 
medical device manufactures when selecting suitable software 
suppliers.  
In this paper we describe the development of the MDevSPICE® 
framework by first explaining the regulatory requirements medical 
device software development companies face before they are able 
to market their devices and how this motivated us to develop the 
MDevSPICE® framework. We will then focus on the lessons we 
learned when validating the framework in expert reviews and in 
industry through MDevSPICE® pilot assessments. We finish the 
paper with a brief summary about the benefits of using process 
assessment in safety-critical domains such as the medical device 
domain in order to better prepare for regulatory audits as well as 
to increase the safety and quality of the developed products.  
2. REGULATORY REQUIREMENTS FOR 
SOFTWARE IN THE MEDICAL DEVICE 
DOMAIN 
2.1 Medical devices and regulation in the EU 
and US 
A medical device can consist entirely of software or have software 
as a component of the overall medical device system. In order to 
be able to market a medical device within a particular region it is 
necessary to comply with the associated regulatory demands. Two 
of the largest global bodies responsible for issuing and managing 
medical device regulation belong to the central governing 
functions of the US and EU. In the US, the Food and Drug 
Administration (FDA) issues the regulation through a series of 
official channels, including the Code of Federal Regulation (CFR) 
Title 21, Chapter I, Subchapter H, Part 820 [1]. Under US 
regulation, there are three medical device safety classifications: 
Class I, Class II and Class III. The medical device safety 
classification is based on the clinical safety of the device. Class I 
devices are not intended to support or sustain human life, and may 
not present an unreasonable risk of harm. A thermometer is a 
Class I device. Class II devices could cause damage or harm to 
humans. An example of a Class II medical device is a powered 
wheelchair. Class III medical devices are usually those that 
support or sustain human life, and are of significant importance in 
the prevention of human health impairment. An example of a 
Class III device is an implantable pacemaker. All implantable 
devices are Class III medical devices as the surgery required 
carries with itself additional high risks from anesthesia and 
possible infections that go beyond the safety risks of the medical 
device.  
In the EU, the corresponding regulation is outlined in the general 
Medical Device Directive (MDD) 93/42/EEC [2], the Active 
Implantable Medical Device Directive (AIMDD) 90/385/EEC [3], 
and the In-vitro Diagnostic (IVD) Medical Device Directive 
98/79/EC [4] - all three of which have been amended by 
2007/47/EC [5]. Similarly to the US, the EU device safety is also 
based on clinical safety of the device embodying similar 
classifications and limitations, where Class I in the EU 
corresponds to Class I in the US, Class IIa and IIb to Class II, and 
Class III to Class III.  
2.2 International standards in the medical 
device domain 
A further safety classification applies to the software in medical 
devices as outlined in IEC 62304:2006 (IEC 62304 from hereon) 
[6], where the safety classification is determined based on the 
worst possible consequence in the case of a software failure. In 
the case of failure of software that is of safety Class A no injury or 
damage to health of a patient can occur. When software of safety 
class B fails, injury may occur but it is not serious or life-
threatening. Class C medical device software is of highest risk and 
in the case of failure of such software death or serious injury can 
happen. Depending on the functionality of software within the 
medical device, the software safety classification may vary from 
the overall medical device safety class. When software is of 
critical functionality of the medical device, it will carry the same 
classification as the device, i.e. Class C software in Class III 
device. The safety classification of software may be lower but 
cannot be higher than the overall medical device safety class, e.g. 
software of safety Class B may be embedded in Class III device 
but there cannot be software of safety Class C in a Class I or Class 
II device. 
Medical device manufacturers in the US as well as in EU must 
satisfy quality system requirements to market their developed 
devices. In the medical device domain, ISO 13485:2003 (ISO 
13485 from hereon) [7] outlines the requirements for regulatory 
purposes from a Quality Management System (QMS) perspective 
in medical device domain. ISO 13485, which is based on ISO 
9001 [8], can be used to assess an organization’s ability to meet 
both customer and regulatory requirements in the medical device 
domain. ISO 13485 does not, however, include requirements for 
software development. IEC 62304, which can be used in 
conjunction with ISO 13485, does offer a framework for the 
lifecycle processes necessary for the safe design and maintenance 
of medical device software. As a basic foundation, IEC 62304 
assumes that medical device software is developed and maintained 
within a QMS such as ISO 13485, but does not require an 
organization to be certified against ISO 13485. Therefore, IEC 
62304 can be considered to be a software development specific 
supplement to ISO 13485, similarly to ISO 90003 for ISO 9001. 
IEC 62304 is based on ISO/IEC 12207:1995 [9] which although a 
comprehensive standard for software development lifecycle 
processes has effectively been decommissioned following the 
publication of the more extensive ISO/IEC 12207:2008 [10]. 
Furthermore, other developments in the ISO and IEC 
communities for software development, such as ISO/IEC 15504 
[11], have provided significant additional levels of software 
process detail to support ISO/IEC 12207:2008. IEC 62304 is a 
critical standard for medical device software developers as it is the 
only standard that provides recommendations for medical device 
software implementations based on the worst consequences in the 
case the software failure causing hazards. Furthermore, for general 
medical device risk management, IEC 62304 is used in 
conjunction with ISO 14971 [12] and IEC 80002-1 [13] that 
provides guidance on the application of ISO 14971 for software 
development. As IEC 62304 considers a medical device system to 
consist of software as its sub-system, the system or product level 
requirements are not included within IEC 62304 but instead 
within the medical device product standard IEC 60601-1 [14]. 
Due to the increasing importance of usability of devices within the 
medical device industry, organizations should also adhere to the 
medical device usability engineering process requirements 
outlined in IEC 62366 [15]. When Medical Device Directives 
were amended in 2007 [5], it allowed standalone software to be 
defined as a medical device in its own right. Previously, software 
had always been seen as a subsystem embedded in a medical 
device. This amendment revealed a gap in international standards 
as none of the published standards were addressing the concerns 
for standalone software as a medical device. Today, IEC CD 
82304-1 [16] applies to the safety of health software that is 
designed to operate on general purpose IT platforms and that is 
intended to be placed on the market without dedicated hardware, 
e.g. iPad applications. 
2.3 FDA and their guidance documents 
All companies planning to market a medical device in the United 
States need to register their product with the US FDA. Most Class 
I devices can be self-registered but most Class II devices require a 
510(k) submission. For Class III devices, a Pre-Market (PMA) 
submission is needed. To support manufacturers in addressing the 
relevant guidance, the FDA has issued an overview of their 
guidance documents for medical device manufacturers and 
software developers [17]. 
The FDA Guidance on Premarket Submissions [18] provides 
guidance and recommendation for premarket submissions for 
software devices, including standalone software applications and 
hardware-based devices that incorporate software. Premarket 
submission includes requirements for software-related 
documentation that should be consistent with the intended use of 
the Software Device and the type of submission. In general terms, 
the medical device manufacturer needs to describe the following 
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in the premarket submissions: a) the design of the device, b) 
documentation about the implementation of that design, c) 
demonstration how the device was tested, d) how hazards were 
appropriately identified and risks effectively managed, e) how 
traceability is established between design, implementation, testing 
and risk management.  
The FDA Guidance on Off-The-Shelf Software Use in Medical 
Devices [19] was published in 1999 with the purpose of 
describing the information that should be provided in a medical 
device application that uses off-the-shelf (OTS) software. Many of 
the principles outlined in this guidance document may also be 
helpful to device manufacturers in establishing design controls 
and validation plans for use of off-the-shelf software in their 
devices.  
The FDA General Principles of Software Validation [20] outlines 
general validation principles that the FDA considers to be 
applicable to the validation of medical device software or the 
validation of software used to design, develop, or manufacture 
medical devices. This guidance describes how certain provisions 
of the medical device Quality System regulation apply to 
software. The scope of this guidance is somewhat broader than the 
scope of validation in the strictest definition of that term. 
Planning, verification, testing, traceability, configuration 
management, and many other aspects of good software 
engineering discussed in this guidance are important activities that 
together help to support a final conclusion that software is 
validated. 
2.4 Medical device software standards vs 
generic software standards 
Numerous different medical device standards and regulations now 
exist, some of which are interlinked with generic software 
development standards and others which are mostly independent. 
The dominant medical device software standards such as IEC 
62304 are not yet aligned with the approach adopted in the 
general software development standards community since the 
1995 publication of ISO/IEC 12207. One significant change in 
this respect has been the introduction of a harmonized approach to 
process description (as defined in ISO/IEC 24774 [21]) which 
involves the identification of core process outcomes that can later 
be harnessed to develop a process assessment method. A further 
significant change relates to the movement in the general software 
development standards community (and in other safety-related 
domains) to include a software process improvement dimension 
that can be instrumental in guiding software development 
organizations towards the required process targets. In effect, the 
medical device standards have not kept up with the changes that 
have been made to the general software development standards. 
There are several reasons why the medical device standards lag 
the updates to the general software development standards, 
(perhaps) most importantly the IEC stability period during which 
adopted harmonized standards are not to be changed unless the 
proposed changes are necessary in terms of safety. With the 
expanding role of software in medical devices, there is a case to 
be made for introducing the accumulated up-to-date wisdom in 
the general software development standards into the medical 
device software development specific standards in a uniform 
fashion – and work in this direction should not wait for the IEC 
stability period to come to an end, but rather proceed in the 
interim period. 
Furthermore, the challenge that software development companies 
in the medical device domain face when they want to market a 
device is in the adherence to a large number of regulatory 
requirements specified in various international standards (that can 
often become overwhelming). In order to help these companies 
better prepare for demanding and costly regulatory audits, we 
developed the MDevSPICE® framework. MDevSPICE® includes 
requirements from the previously mentioned standards and 
guidance documents rendering the task of regulatory compliance 
much less complex. Following is a detailed description of the 
development of the MDevSPICE® framework that integrates the 
requirements from various international medical device standards 
and guidance documents with the generic software development 
best practices while providing a possibility to assess processes.  
3. DEVELOPMENT OF THE MDEVSPICE® 
FRAMEWORK 
3.1 MDevSPICE® Process Reference Model 
A process reference model (PRM) describes a set of processes in a 
structured manner through a process name, process purpose and 
process outcomes where the process outcomes are the normative 
requirements the process should satisfy to achieve the purpose of 
the process. In order to develop a PRM that integrates 
requirements from various standards allowing the processes to be 
evaluated in terms of their achievement of their purpose 
statements, we followed the format of the process description 
illustrated in ISO/IEC 24774 [21]. With that in mind, we first 
mapped and integrated the requirements from ISO/IEC 
12207:2008 and IEC 62304 into what today is called the Process 
Reference Model for IEC 62304 (but which also reflects the 
updates to ISO/IEC 12207 from the 1995 to the 2007 version). A 
systematic approach of memoing and constant comparison, which 
is based on the principles of Grounded Theory [22]  was followed 
when developing the PRM, further details of which are to be 
found in [23]. The approach of memoing and constant comparison 
is suitable for systematically integrating information from various 
different sources [24]. The Process Reference Model of IEC 
62304 was published in June 2014 as IEC TR 80002-3 [25]. 
While IEC 62304 describes only the software life cycle processes, 
additional processes should be in place for system development in 
the case where software is not embedded as part of an overall 
medical device. These additional processes were derived from 
ISO/IEC 12207:2008. Design and development related 
requirements from ISO 13485 and ISO 14971 were also added to 
the MDevSPICE® Process Reference Model. Both ISO 13485 and 
ISO 14971 are de facto standards for medical device software 
organizations. ISO 13485 requirements are primarily related to 
system level processes and ISO 14971 is concerned with risk 
management (and therefore aligned with the Software Risk 
Management process of the PRM.  
ISO 13485 requirements were integrated into the MDevSPICE® 
PRM through relevant new Process Outcomes where no 
corresponding ones already existed, or as Notes where 
corresponding Process Outcomes were already in place. Some of 
the QMS requirements target higher Capability Levels, in which 
case the requirements were related to Generic Practices Process 
Attribute (PA) 2.1 (e.g. on allocating resources) or to PA 2.2 (e.g. 
on documentation) on Capability Level 2. The outcomes or notes 
derived from ISO 13485 are highlighted in the MDevSPICE® 
PRM to visualize the source standard.  
ISO 14971 distributes the risk management related requirements 
across all software life cycle processes. To avoid major 
duplication, the risk management requirements were kept only 
within the Software Risk Management process of the main body 
of the PRM. Instead of distributing these requirements across life 
cycle processes, a table was added in the Annex of the PRM that 
lists the specific risk management requirements for each software 
life cycle process. These requirements need to be added to the 
selected software life cycle processes for process assessment in 
the case where the process assessment will not include the 
Software Risk Management process in its entirety.  
The final MDevSPICE® PRM consists of 23 processes of which 
10 are system life cycle processes, 8 are software life cycle 
processes and the remaining 5 support both the system and life 
cycle processes as can be seen in Figure 1.  
Figure 1. Processes of MDevSPICE® PRM 
The MDevSPICE® PRM was then extended with additional 
elements to create a process assessment model (PAM) described 
in greater detail in the following section. 
3.2 From process reference model to process 
assessment model 
Process assessment provides software development companies 
with a capability profile of their development processes, their 
strengths and weaknesses in relation to the normative 
requirements of a model with the aim to improve processes and 
close the discovered gaps. While the generic software 
development domain is moving away from best practice 
implementation [26] and towards agile and scrum practices, 
companies operating in safety-critical sectors such as the medical 
device domain have to demonstrate the compliance of their design 
and development processes with regulatory requirements together 
with the evidence of detailed documentation.  
The aim of the MDevSPICE® PAM is to provide a comprehensive 
model for assessing the software and systems development 
processes against the widely recognized medical device 
regulations, standards and guidelines that a software development 
organization in the medical device domain has to adhere to. The 
MDevSPICE® PAM, similar to ISO/IEC 15504-5 (SPICE) [27], 
has two dimensions – a process dimension and a capability 
dimension. The process dimension lists three groups of processes 
from various models and standards, i.e. systems life cycle 
processes, software life cycle processes and support processes. 
Each process is described in terms of a Process Name, Process 
Purpose, Process Outcomes, Base Practices, Work Products and 
Work Product Characteristics. As already noted, Process 
Outcomes are the normative requirements within a process, the 
achievement of which will allow satisfying the Process Purpose 
statement. Base Practices are informative activities that illustrate 
one possible way (workflow) to achieve the corresponding 
Process Outcomes. Work Products are artefacts that are either 
produced or used by the Base Practices, and support the 
achievement of the Process Outcome. Each Work Product is 
further described in terms of its content called the Work Product 
Characteristics. In the case of the 
MDevSPICE® PAM, some of 
these Work Products are 
normative as they are based on 
the requirements derived from 
IEC 62304, ISO 14971 or ISO 
13485. Similarly, their content 
may have been specified in these 
standards, and if that is the case, 
this information has been carried 
forward to the Work Products 
Characteristics of the 
MDevSPICE® PAM.  
Figure 2 below describes the 
different sources of the 
MDevSPICE® PRM and PAM. 
The MDevSPICE® PRM is 
based on IEC 62304, ISO/IEC 12207:2008, ISO 14971 and ISO 
13485. The MDevSPICE® PAM then extends this PRM with base 
practices and work products, some of the latter also being 
normative as they are described in IEC 62304, ISO 14971 or ISO 
13485 as requirements. Where process outcomes are derived from 
ISO/IEC 12207:2008, their corresponding base practices and 
work products are derived from ISO/IEC 15504-5. Where process 
outcomes are derived from ISO 14971, their corresponding base 
practices are derived from IEC 80002-1. In addition to these 
sources, FDA guidance on premarket submissions, software 
validation and off-the-shelf software have been added to the 
informative base practices where the base practice did not already 
address the requirements of the corresponding FDA guidance. 
Product safety requirements have been added to the 
MDevSPICE® PAM from both IEC 60601-1 and IEC CD 82304-
1, while the usability engineering requirements have been 
incorporated from IEC 62366. 
The capability dimension of the MDevSPICE® PAM is derived 
directly from ISO/IEC 15504 together with the Capability Levels, 
Process Attributes, Generic Practices, Generic Resources and 
Generic Work Products. 
 
 
Figure 2. Standards integrated in the MDevSPICE® PAM 
 
In order to scope an MDevSPICE® assessment, various 
requirements need to be taken into account, including the 
classification of the medical device software and the standards and 
guidance documents to be considered. With the exception of IEC 
62304, all other integrated international standards and guidance 
documents can be scoped or de-scoped from the assessment. 
MDevSPICE® process assessments provide a detailed overview of 
the medical device software development processes together with 
any gaps discovered to the normative 
requirements of the MDevSPICE® 
model. MDevSPICE® process 
assessment results describe the capability 
of each assessed process as well as the 
compliance to any of the chosen 
standards’ requirements that are in the 
MDevSPICE® PAM. 
3.3 From process 
assessment model to process 
assessment framework 
A process reference model and a process 
assessment model are not enough to provide a solid basis for 
conducting new domain-specific process assessments in a 
repetitive and consistent manner. Therefore, the MDevSPICE® 
process assessment method was developed to describe precisely 
how an MDevSPICE® process assessment should be conducted, 
(as illustrated in Figure 3). The MDevSPICE® training and 
assessor certification schemes provide the knowledge and 
structure that the certified MDevSPICE® assessors need to 
conduct MDevSPICE® assessments.  
There are various roles involved in an MDevSPICE® assessment – 
the key roles are that of a Sponsor, an MDevSPICE® Principal or 
Lead Assessor and the other MDevSPICE® assessor(s). The latter 
two roles form an Assessment Team. The assessment Sponsor is 
either a person or an entity that requests the performance of an 
MDevSPICE® assessment and who provides financial and other 
resources for the assessment. The assessment Sponsor can be 
either internal to the assessed organization or external, e.g. when a 
software supplier’s process capability is to be determined. 
According to the MDevSPICE® Assessor Certification Scheme, 
there are three types of assessors: a Principal MDevSPICE® 
assessor, a Lead MDevSPICE® assessor and an MDevSPICE® 
assessor. An MDevSPICE® Lead Assessor who can perform 3rd 
party assessments is called the Principal assessor.  
The Assessment Team members must have 
a firm understanding of the MDevSPICE® 
Process Reference Model (PRM), the 
MDevSPICE® Process Assessment Model 
(PAM) and the related Medical Device 
standards and regulations. The Assessment 
Team must also have an understanding of 
the organizational unit, the organizational 
culture and the different geographic 
locations involved in the assessment. This 
understanding plays a crucial role in the 
overall execution of the assessment.  
MDevSPICE® process assessments are 
typically performed to provide a gap 
analysis and/or to establish the strengths and weaknesses of the 
organization’s processes while evaluating the capability of these 
processes against specific requirements. An MDevSPICE® 
process assessment can be performed as a) a process evaluation 
before regulatory audits, b) a gap analysis as a part of an internal 
process improvement program, and/or c) a capability 
determination of specific processes to determine the suitability of 
an organization in supplying software for medical devices (where 
the devices may be manufactured by another organization).  
 
 
 
 
 
 
 
Figure 3. Overview of 
the MDevSPICE® assessment method 
The MDevSPICE® process assessment method has 5 main phases 
(refer to the activities in Figure 3) from planning the assessment 
to reporting the results. The amount of evidence required in a 
process assessment depends on the purpose and the class of the 
assessment. As a result of an MDevSPICE® process assessment, 
the assessed company is provided with a detailed assessment 
report about their processes. The main components of a process 
assessment output are the process profiles, which provide a 
structured representation of an individual process capability. 
These process profiles are then compared with the target profiles 
defined prior to the assessment based on the organization’s 
expectations and constraints. This enables a clear understanding 
of the gaps to be covered in order to reach the target profile.  
 
4. VALIDATION OF THE FRAMEWORK 
The MDevSPICE® framework has been validated in various stages 
of its development by different parties through both international 
expert review and industrial trials. The foundation of the 
MDevSPICE® PAM, IEC TR 80002-3 (the development of which 
was led by the authors), was published after several iterations of 
development and analysis by the standardization working group 
responsible for the publication of IEC 62304 (i.e. ISO/IEC Sub-
Committee 62A, Joint Working Group 3). An international 
standard is published only after the national delegates of the 
standard’s working group have agreed on every detail of that 
standard. As a result of this validation, one of the important 
lessons concerned the use of terminology in the MDevSPICE® 
PAM. Namely, the language and terminology used in the medical 
device software  domain is slightly different from that used within 
generic software development. The terminology  adopted in the 
MDevSPICE® PAM is in line with that used within the standards 
and guidance documents used within the  medical device software 
domain in order to enable  easier adoption of the new model 
within the domain. 
In addition to working with the international medical device 
standards community, the MDevSPICE® PAM has also been  
developed together with and analyzed by experts in process 
assessment working group 10 of ISO/IEC Joint Technical 
Committee 1, Sub-Committee 7, responsible for the development 
and maintenance of the series of process assessment standards. 
These standards are currently being revised from ISO/IEC 15504 
series to ISO/IEC 330xx series of standards. MDevSPICE® 
framework keeps abreast of these updates as well as with the 
updates of any other standard and guidance document information 
from which is contained in the MDevSPICE® framework.  
Upon successful completion of international expert review, the 
MDevSPICE® process assessment framework was then validated 
in the medical device software industry through pilot assessments 
over the past two years. MDevSPICE® process assessments were 
conducted in different types of organizations: (1) a small software 
company wishing to supply software to a large  medical device 
manufacturer who wants them to demonstrate that they are 
capable of developing safe medical device software and provide 
the medical device manufacturer with a feeling that they will not 
jeopardize the safety of their overall medical device or the 
reputation of their organization;(2) three different assessments 
(across a 2 year period) were performed in two different 
international sites of  a multinational  medical device 
manufacturer who wants to ensure that they are incorporating best 
practices within their software development processes to not only 
achieve regulatory compliance but also reduce the likelihood of 
recalls through developing better quality and more robust 
software; (3) a  software development company seeking to achieve  
regulatory compliance against IEC 62304 so that they can become 
medical device software suppliers; and (4) a large automotive 
manufacturer experienced in developing safety-critical embedded 
automotive software now wishing to also develop embedded  
medical device software.  
5. DISCUSSION – LESSONS LEARNED 
As a result of the MDevSPICE® pilot assessments we have 
witnessed different types of needs in different companies. We can 
categorize these companies based on their position in and 
compliance to regulatory requirements in the medical device 
domain – first, there are the software companies that want to enter 
the medical device domain. They either require knowledge and 
information about the regulatory requirements they have to satisfy 
before they can market their device, or they want detailed 
instructions in terms of design, development and maintenance of 
medical device software. Second, there are the large medical 
device companies who already market some of their developed 
devices. They require help either in preparation for regulatory 
audits for new devices under development, or to improve their 
existing software development processes to enable higher quality 
software therefore reducing the risk of recalls in order to become 
or stay leaders in the market.  
In order for the software developers entering the medical device 
domain to market their devices they have to start by implementing 
a Quality Management System including a Risk Management 
process, which involves  adopting ISO 13485 and ISO 14971.  
Companies with QMS in place but unsure that their software 
development is compliant with the requirements of ISO 13485 
and IEC 62304 stand to derive great benefit from undertaking an 
MDevSPICE® process assessment. As a result of such process 
assessment, the company not only obtains a detailed overview of 
their development processes but gains  an understanding of the 
gaps to be addressed in order to obtain  compliance against one of 
more of the medical device software standards (e.g. IEC 62304, 
IEC 80002-1 etc.). Similarly, existing medical device 
manufacturers who want to ensure that they can pass a regulatory 
audit can use a process assessment to discover any possible 
weaknesses in their development processes. The findings from a 
process assessment contain a detailed list of strengths, weaknesses 
and associated process improvement recommendations that should 
be implemented in order to achieve a particular goal e.g pass an 
IEC 62304 audit or satisfy FDA guidance on software validation 
or reach MDevSPICE® capability level 3 thus maximizing the 
possibility of safe product implementation.  
Medical device manufacturers who want to remain market leaders 
must ensure that their devices are safe and will not be recalled due 
to a software fault. Large medical device manufacturers therefore 
reduce the risk of recalls through adopting the latest best practice 
techniques and standards. Such companies will have IEC 62304 
compliant software development processes and this is where the 
capability dimension of MDevSPICE® becomes important. These 
companies can still improve the planning, management and 
implementation of their processes together with the input and 
output documentation of these processes, as well as standardizing 
their development processes across their development department. 
Significantly, such companies also want to ensure that their 
software suppliers are also adopting similar quality software 
development processes and an MDevSPICE® assessment can be 
used to evaluate their suppliers’ processes.  
A key finding from performing the pilot MDevSPICE® 
assessments was that the companies derived significant value not 
just from obtaining feedback in a textual manner but also in a 
graphical representation across each of the various medical device 
standards within MDevSPICE®. Additionally, when conducting 
MDevSPICE® assessments it was important to follow the natural 
order of the software development lifecycle. Finally, due to the 
fact that an MDevSPICE® assessment covers multiple standards it 
was important that a scripted set of questions were followed to 
ensure that all intended standards’ requirements were adequately 
covered. 
6. SUMMARY  
This paper describes the benefits process assessments can bring to 
companies in a safety-critical domain. Safety-critical domains are 
characterized by heavy regulatory demands that companies have 
to adhere to before they can market their devices. Regulatory 
audits are conducted regularly to evaluate these companies and 
the safety of their developed devices. Process assessments can 
help medical device software developers to better prepare 
themselves for resource-demanding and costly audits. For that 
purpose, we have developed a medical device software process 
assessment framework called MDevSPICE® that integrates 
requirements from all the major relevant international standards 
and guidance documents of the medical device domain. We have 
illustrated the framework in this paper and elaborated on the 
lessons we learned when validating the framework in industry, 
resulting in a thorough understanding of the benefits that process 
assessments bring to safety-critical domains.  
Having assembled a multi-disciplinary internationally recognized 
team, the MDevSPICE® framework has been systematically and 
carefully developed in the Regulated Software Research Center 
based at Dundalk Institute of Technology. Many years of 
sustained research and development have produced the 
MDevSPICE® framework which has - for the first time – 
consolidated the various disparate medical device standards and 
guidance into one single location. MDevSPICE® has furthermore 
integrated the accumulated best practices from generic software 
development and provided a robust assessment vehicle as a means 
to evaluating process capability. This represents a significant step 
forward for medical device software development as it reduces the 
complexity of various standards and guidance into one single 
repository while also enabling a robust investigation of process 
implementation. Over the coming years, medical device 
manufacturers should derive significant benefit from these 
advancements. The first step along this road will involve the 
training and certification of MDevSPICE® Assessors – an activity 
that is due to commence 
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